Friday, May 27, 2011
Tethys’ simple blood test, which scores the risk of pre-diabetics getting full-blown type 2 diabetes within five years, hit the market in early 2009 to scientific applause. The test, called PreDx (sounds like “predicts”), could help doctors concentrate on their highest-risk patients and change the course of the disease, according to Emeryville-based Tethys.
There’s one problem: getting doctors to give the test. Their focus is typically on treatment, not prevention, said Tethys CEO Mickey Urdea.